http://www.pharmaceutical-technology.com/news/fda-approves-first-oral-treatment-postpartum-depression/
0
0
8/7/23 at 1:56pm
Organization
Pharmaceutical Technology
Author
Phalguni Deswal
27 words
0
Comments
Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in the last quarter of 2023.
You are the first to view
Create an account
or login to join the discussion